Q517--Contingency Chemotherapy Compounding Services Louis A Johnson VA Medical Center

Louis A. Johnson VA Medical Center (LAJVAMC) Inpatient Pharmacy is issuing a Sources‑Sought notice to identify qualified contractors capable of providing contingency hazardous chemotherapy compounding services should the pharmacy’s sole IV compounding room become unavailable. The contractor must aseptically compound all patient‑specific hazardous chemotherapy agents, supply all required drugs, IV tubing, closed‑system drug‑transfer devices, and related items, and deliver three copies of each Safety Data Sheet on the day materials arrive. The effort includes a base year of performance from 27 Aug 2026 to 26 Aug 2027 with up to four one‑year options through 26 Aug 2031, and requires compliance with federal records‑management and subcontractor‑flow‑down clauses. Small‑business respondents must be able to perform at least 51 % of the work. Interested firms should submit a capability statement by 15:00 EST, 25 Mar 2026, via email only to sylvia.honesty@va.gov. Submissions must include business name, type, socio‑economic status (e.g., Veteran‑Owned, Woman‑Owned, 8(a), etc.), a point‑of‑contact with phone and email, and any applicable GSA contract number with its ultimate completion date. This RFI is for market research only; no contract award is contemplated at this time.

Notice ID

4031ffbb8c0142cfa2bb03850f5e3977

Solicitation Number

36C24526Q0356

NAICS Code

456110

Classification Code

Q517